CoA-S-acetyl 5-bromotryptamine

Star0

DB03341ExperimentalSmall molecule

CoA-S-acetyl 5-bromotryptamine: Overview.

Formula / weight: C₃₃H₄₇BrN₉O₁₇P₃S · 1046.667 g/mol (avg)

Resolves to

Compound

PubChem446811

Structure

InChIKeyBBDVCGJBELWXIQ-GMHMEAMDSA-NSMILES

[H]N([H])C1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)N([H])CCC(=O)N([H])CCSCC(=O)N([H])CCC4=CN([H])C5=C4C=C(Br)C=C5)[C@@H](OP(O)(O)=O)[C@H]3O)C2=NC=N1

Targets

Q16613AANAT

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with CoA-S-acetyl 5-bromotryptamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account